HHC Cancer Institute is leveraging a strategic partnership with Memorial Sloan Kettering Cancer Center, while Boruchov has succeeded Yu as physician-in-chief.
1 report, 1 independent
Updated Jul 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
HHC Cancer Institute is leveraging a strategic partnership with Memorial Sloan Kettering Cancer Center, while Boruchov has succeeded Yu as physician-in-chief.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Memorial Sloan Kettering Cancer Center
cancer treatment and research institution in New York City, United States
Related events
Coverage
Newest first; wire copies grouped- hartfordbusiness.comHartford HealthCare names new Cancer Institute chief